Biofermin Market

Lactase is a drying agent of live enterococcus. It decomposes sugars into lactic acid in the intestine, which increases the acidity of the intestine, inhibits the growth and reproduction of putrefactive bacteria, prevents intestinal fermentation and reduces gas production, thus promoting digestion and stopping diarrhea.
Biofermin Market contains market size and forecasts of Biofermin in global, including the following market information:
Global Biofermin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Biofermin Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Biofermin companies in 2021 (%)
The global Biofermin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Biofermin include Guilin Pharmaceutical, Sinoway Pharmaceutical, Hebei Huanhai Pharmaceutical, Hebei Tianyuan Pharmaceutical, Shandong Baiwei Pharmaceutical, Huibei Widely Chemical Technology, Okobaike Biotechnology and Taisho, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biofermin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biofermin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Biofermin Market Segment Percentages, by Type, 2021 (%)
Tablets
Powdery
Other
Global Biofermin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Biofermin Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Biofermin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Biofermin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biofermin revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Biofermin revenues share in global market, 2021 (%)
Key companies Biofermin sales in global market, 2017-2022 (Estimated), (MT)
Key companies Biofermin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Guilin Pharmaceutical
Sinoway Pharmaceutical
Hebei Huanhai Pharmaceutical
Hebei Tianyuan Pharmaceutical
Shandong Baiwei Pharmaceutical
Huibei Widely Chemical Technology
Okobaike Biotechnology
Taisho